Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Magneto-Electrochemical Nanobioelectronic Device for Simultaneous Extraction and On-chip Detection of Cancer Biomarker in Cell Lysate.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Visualizing immunoreceptor forces and their effects in vivo.

bioRxiv : the preprint server for biology·2026

Same author

Smoking inequalities among culturally diverse populations in Australia: A secondary dataset analysis of the HILDA survey 2002-2019.

Tobacco induced diseases·2026

Same author

Activating antiviral defenses warms up cold tumours.

Nature nanotechnology·2026

Same author

The Impact of Front-of-Pack Labeling on Social Inequality in Sugar Consumption and Purchase: A Systematic Review.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026

Same author

DNA cross-over motifs-based, programmable supramolecular hydrogels for the mechanoregulatory effects of cellular behaviour and cytoskeleton reorganization.

npj biomedical innovations·2026

Search research articles

Related Experiment Video

Updated: May 4, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Engineering vaccines and niches for immune modulation.

Alberto Purwada¹, Krishnendu Roy², Ankur Singh³

¹Department of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.

Acta Biomaterialia

|December 31, 2013

Summary

Biomaterials can be engineered to control immune responses for therapies like cancer vaccines and autoimmune treatments. This approach trains immune cells to fight diseases effectively.

Keywords:

Biomaterials Immunoengineering Immunomodulation Niches Vaccines

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 4, 2026

Murine Model of Epicutaneously-Induced Immunomodulation

Murine Model of Epicutaneously-Induced Immunomodulation

Published on: June 24, 2025

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

Immunoengineering
Biomaterials Science
Immunology

Background:

Controlled modulation of immune responses is crucial for diverse clinical applications, including cancer immunotherapies, infectious disease treatments, and autoimmune disorder management.
Immunoengineering leverages quantitative tools to understand and control immune system interactions, with biomaterials serving as a key component.
Existing research often focuses on immune evasion for implants; this review highlights biomaterials for immunostimulation and controlled modulation.

Purpose of the Study:

To review the use of biomaterials for immunostimulation and controlled modulation of immune responses.
To discuss design aspects for biomaterials that actively modulate immune responses for next-generation immunotherapeutics.
To emphasize the role of biomaterials in vaccines and immunotherapies against cancer, infectious diseases, and autoimmune disorders.

Main Methods:

Focuses on a review of existing literature concerning biomaterials for immune modulation.
Discusses the exploitation of biomaterials' intrinsic biological and mechanical cues to train immune cells.
Highlights the design of smart systems for controlled delivery of bioactive agents and in situ immune modulation.

Main Results:

Biomaterials can be designed to actively modulate immune responses by engaging receptor complexes and cells.
Engineered biomaterials can deliver multiple immunomodulatory biomolecules in a controlled manner.
Smart biomaterial systems can create niches for in situ immune priming and modulation, enhancing therapeutic efficacy.

Conclusions:

Biomaterials are integral to immunoengineering, offering design-driven approaches to control immune responses.
Strategic use of biomaterials can enhance the efficacy of vaccines and immunotherapies.
Future directions involve bioengineering smart systems for precise immune modulation in treating cancer, infectious, and autoimmune diseases.